Liposomal Bupivacaine vs Standard Bupivacaine for Post-Rhinoplasty Analgesia
Start Date
8/1/2026
Completion Date
7/1/2027
Summary
The purpose of this study is to find out which pain medication is more effective in reducing pain after nose surgery (rhinoplasty). The investigators are looking to find the best treatment to reduce discomfort and improve the healing process for patients having nose surgery.
Detailed Description
The investigators are comparing two types of pain relief medications: Liposomal Bupivacaine and Standard Bupivacaine. Participants who are undergoing rhinoplasty will be randomly assigned to receive either Liposomal Bupivacaine or Standard Bupivacaine during their surgery. Both medications are given as nerve blocks, which means they are injected near nerves to block pain signals. After the surgery, participants will be asked to rate their pain levels over several days. The investigators will also monitor any side effects and how quickly participants recover from the surgery.
Eligibility Criteria
Age Range: 18 years to No maximum
Interventions
Standard Bupivacaine
Liposomal Bupivacaine
Conditions
Locations
Washington University
St Louis, Missouri 63110
United States